Combination of Potassium Iodide and Propranolol in Preparation of Patients with Graves' Disease for Thyroid Surgery

Abstract
We assessed the efficacy of the combination of propranolol and potassium iodide in the preparation of patients with Graves' disease for thyroid surgery. Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol. In contrast to previous experience with either drug used singly, the combined regimen caused a significant fall in mean serum total thyroxine and triiodothyronine to levels in the euthyroid range before operation (P<0.001). There was also a significant fall (P<0.05) before operation and a transient rise after operation in serum reverse triiodothyronine.